3
Announcements
Trials
Browse
Landscape
Status
Unknown
10
Completed
4
Withdrawn
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Ornithine Carbamoyltransferase Deficiency Disease
1
Obesity, Morbid
1
Neurologic Manifestations
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Gynecological Cancer
1
Genital Diseases, Female
1
Endometrial Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Brain Neoplasms
1
Interventions
Capecitabine
29
Oxaliplatin
28
Fluorouracil
16
Radiotherapy
15
Drug Therapy
11
Leucovorin
10
Bevacizumab
10
Surgical Procedures, Operative
9
Chemoradiotherapy
8
Radiation
7
sintilimab
6
Consolidation Chemotherapy
6
tislelizumab
5
spartalizumab
5
XELOX
5
Specimen Handling
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
Neoadjuvant Therapy
4
Endoscopy
4
Cetuximab
4
Biopsy
4
toripalimab
3
pembrolizumab
3
irinotecan sucrosofate
3
X-Rays
3
Radiotherapy, Intensity-Modulated
3
Proctectomy
3
Mastectomy, Segmental
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Rectal Neoplasms
×
Laparoscopy
×
Clear all
NCT01762813
2026-04-30
ACROBATICC
Helse Stavanger HF
Recruiting
1,200 enrolled